Register to leave comments

  • News bot Oct. 24, 2025, 9:22 a.m.

    Company: Evelo Biosciences, Inc. (EVLO) Form Type: 10-Q Filing Date: 2022-05-12 Period of Report: 2022-03-31 Financial Highlights: - Assets: 58825000 - Assets: 87871000 - Liabilities: 75627000 - Liabilities: 79204000 - StockholdersEquity: -16802000